市場調查報告書

瘧疾診斷的全球市場 - 各產品種類 (迅速診斷檢驗,顯微鏡檢驗,分子診斷檢驗)、各終端用戶 (醫院,診療所,診斷中心):機會分析與產業預測 (2019∼2026年)

Malaria Diagnostics Market by Product Type (Rapid Diagnostic Tests, Microscopy, and Molecular Diagnostic Tests) and End User (Hospital, Clinics, Diagnostic Centers) Global Opportunity Analysis and Industry Forecast, 2019-2026

出版商 Allied Market Research 商品編碼 938379
出版日期 內容資訊 英文 171 Pages
商品交期: 2-3個工作天內
價格
瘧疾診斷的全球市場 - 各產品種類 (迅速診斷檢驗,顯微鏡檢驗,分子診斷檢驗)、各終端用戶 (醫院,診療所,診斷中心):機會分析與產業預測 (2019∼2026年) Malaria Diagnostics Market by Product Type (Rapid Diagnostic Tests, Microscopy, and Molecular Diagnostic Tests) and End User (Hospital, Clinics, Diagnostic Centers) Global Opportunity Analysis and Industry Forecast, 2019-2026
出版日期: 2020年03月05日內容資訊: 英文 171 Pages
簡介

全球瘧疾診斷的市場規模在2018年估算為7億2887萬美元,2026年將成長到10億8510萬6000美元的規模,並以5.1%的年複合成長率成長。市場成長的大要素,是發展中國家的患病人數的增加,及各國政府的支援強化,研究開發的發展等。

本報告提供全球瘧疾診斷的市場相關分析,疾病、技術概要和市場基本結構、最新趨勢,主要的推動及阻礙市場要素,今後的市場機會,市場規模的成果值、預測值 (今後8年份),各產品種類、各終端用戶、各地區的詳細趨勢,主要企業的簡介等相關調查。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要企業的定位
    • 主要的投資財源
  • 瘧疾診斷產業/市場形成的主要原因
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第4章 瘧疾診斷市場:各產品種類

  • 概況
    • 市場規模與其預測
  • 迅速診斷檢驗
  • 顯微鏡檢驗
  • 分子診斷檢驗

第5章 瘧疾診斷市場:各終端用戶

  • 概況
  • 醫院
  • 診療所
  • 診斷中心

第6章 瘧疾診斷市場:各地區

  • 概況
  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第7章 企業簡介

  • Abbott Laboratories
  • Access Bio. Inc.
  • Atlas Medical
  • BIOMERIEUX SA
  • Bio-Rad Laboratories, Inc.
  • Meridian Bioscience Inc.
  • NOVARTIS AG
  • Olympus
  • Premier Medical Corporation Pvt Ltd.
  • SIEMENS
目錄
Product Code: A00195

The global malaria diagnostics market accounted for $728,870 thousand in 2018 and is expected to reach $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026.

Malaria is an infectious ailment caused by the transmission of Plasmodium parasite. These parasites are transmitted through the bite of infected female Anopheles mosquito. Furthermore, these parasites invade cells of the liver, where they grow and multiply to further invade red blood cells. The mature form of these parasites lead to rupturing of blood cells to form merozoites. In addition, these merozoites further invade other red blood cells, which causes symptoms such as high fever, fatigue, and dizziness. Thus, malaria is highly fatal if left untreated for a long period of time. Tests and procedures which are employed in the identification of malaria are called as malaria diagnostics. Furthermore, there are different types of malaria diagnostics available in the market, which include rapid diagnostic tests, microscopy, and molecular diagnostic tests. In addition, these tests are performed in hospitals, clinics, and diagnostic centers.

The major factor that contributes to the growth of the malaria diagnostics market include rise in prevalence of malaria in developing countries. Furthermore, surge in awareness initiatives by governments and increase in research for new malaria diagnostics are the factors that boost the growth of the market. However, lack of awareness about healthcare in developing countries is a major factor that restricts the market growth. Conversely, growth opportunities exhibited by emerging economies is expected to offer lucrative opportunities during the forecast period.

The malaria diagnostics market is studied on the basis of product type, end user, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into rapid diagnostic tests, microscopy, and molecular diagnostic tests. By end user, it is bifurcated into hospital, clinics, and diagnostic centers. Region wise, it is analyzed across North America (the U.S., and Canada, and Mexico), Europe (Germany, the UK, and rest of Europe), Asia-Pacific (China, India, and rest of Asia-Pacific), and LAMEA (Africa and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis along with the current global malaria diagnostics market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.

The market size and estimations are based on a comprehensive analysis of key developments in the industry.

A qualitative analysis based on innovative products facilitates strategic business planning.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Drug Class

Rapid Diagnostic Tests

Microscopy

Molecular Diagnostic Tests

By End User

Hospital

Clinics

Diagnostic Centers

By Region

North America

U.S.

Canada

Europe

Germany

UK

Rest of Europe

Asia-Pacific

China

India

Rest of Asia-Pacific

LAMEA

Africa

Rest of LAMEA

List of key players profiled in the report:

  • Abbott Laboratories
  • Access Bio. Inc.
  • Atlas Medical
  • Biomerieux SA
  • Bio-Rad Laboratories, Inc.
  • Meridian Bioscience Inc
  • Novartis AG
  • Olympus Corporation
  • Premier Medical Corporation Pvt Ltd.
  • Siemens AG
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request)
  • Nikon Corporation
  • Thermo Fisher Scientific

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
    • 1.2.1. List of key players profiled in the report
  • 1.3. Research methodology
    • 1.3.1. Primary research
    • 1.3.2. Secondary research
    • 1.3.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. Key findings of the study
  • 2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Top player positioning
    • 3.2.1. Top investment pockets
  • 3.3. Key forces shaping malaria diagnostics industry/market
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of malaria
      • 3.4.1.2. Surge in healthcare expenditure worldwide
      • 3.4.1.3. Rise in adoption of malaria diagnostics across the globe
    • 3.4.2. Restraint
      • 3.4.2.1. Poor demand in under developed countries
    • 3.4.3. Opportunity
      • 3.4.3.1. High growth potential in developing economies
    • 3.4.4. Impact Analyses

CHAPTER 4: MALARIA DIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Rapid Diagnostic Tests
    • 4.2.1. Key market trends, growth factors, and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market analysis by country
  • 4.3. Microscopy
    • 4.3.1. Key market trends, growth factors, and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market analysis by country
  • 4.4. Molecular Diagnostic Tests
    • 4.4.1. Key market trends, growth factors, and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market analysis by country

CHAPTER 5: MALARIA DIAGNOSTICS MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals
    • 5.2.1. Market size and forecast, by region
    • 5.2.2. Market analysis by country
  • 5.3. Clinics
    • 5.3.1. Market size and forecast, by region
    • 5.3.2. Market analysis by country
  • 5.4. Diagnostic Centers
    • 5.4.1. Market size and forecast, by region
    • 5.4.2. Market analysis by country

CHAPTER 6: MALARIA DIAGNOSTICS MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. North America
    • 6.2.1. Key market trends and opportunities
    • 6.2.2. Market analysis, by country
      • 6.2.2.1. U.S.
      • 6.2.2.1.1. U.S. market size and forecast, by product type
      • 6.2.2.1.2. U.S. market size and forecast, by end user
      • 6.2.2.2. Canada
      • 6.2.2.2.1. Canada market size and forecast, by product type
      • 6.2.2.2.2. Canada market size and forecast, by end user
    • 6.2.3. North America market size and forecast, by product type
    • 6.2.4. North America market size and forecast, by end user
  • 6.3. Europe
    • 6.3.1. Key market trends and opportunities
    • 6.3.2. Market analysis, by country
      • 6.3.2.1. Germany
      • 6.3.2.1.1. Germany market size and forecast, by product type
      • 6.3.2.1.2. Germany market size and forecast, by end user
      • 6.3.2.3. UK
      • 6.3.2.3.1. UK market size and forecast, by product type
      • 6.3.2.3.2. UK market size and forecast, by end user
      • 6.3.2.4. Rest of Europe
      • 6.3.2.4.1. Rest of Europe market size and forecast, by product type
      • 6.3.2.4.2. Rest of Europe market size and forecast, by end user
    • 6.3.3. Europe market size and forecast, by product type
    • 6.3.4. Europe market size and forecast, by end user
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends and opportunities
    • 6.4.2. Market analysis, by country
      • 6.4.2.1. India
      • 6.4.2.1.1. India market size and forecast, by product type
      • 6.4.2.1.2. India market size and forecast, by end user
      • 6.4.2.2. China
      • 6.4.2.2.1. China market size and forecast, by product type
      • 6.4.2.2.2. China market size and forecast, by end user
      • 6.4.2.3. Rest of Asia-Pacific
      • 6.4.2.3.1. Rest of Asia-Pacific market size and forecast, by product type
      • 6.4.2.3.2. Rest of Asia-Pacific market size and forecast, by end user
    • 6.4.3. Asia-Pacific market size and forecast, by product type
    • 6.4.4. Asia-Pacific market size and forecast, by end user
  • 6.5. LAMEA
    • 6.5.1. Key market trends and opportunities
    • 6.5.2. Market analysis, by country
      • 6.5.2.1. Arica
      • 6.5.2.1.1. Arica market size and forecast, by product type
      • 6.5.2.1.2. Arica market size and forecast, by end user
      • 6.5.2.2. Rest of LAMEA
      • 6.5.2.2.1. Rest of LAMEA market size and forecast, by product type
      • 6.5.2.2.2. Rest of LAMEA market size and forecast, by end user
    • 6.5.3. LAMEA market size and forecast, by product type
    • 6.5.4. LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES

  • 7.1. Abbott Laboratories
    • 7.1.1. Company overview
    • 7.1.2. Company snapshot
    • 7.1.3. Operating business segments
    • 7.1.4. Product portfolio
    • 7.1.5. Business performance
  • 7.2. Access Bio. Inc.
    • 7.2.1. Company overview
    • 7.2.2. Company snapshot
    • 7.2.3. Operating business segments
    • 7.2.4. Product portfolio
    • 7.2.1. Key strategic moves and developments
  • 7.3. Atlas Medical
    • 7.3.1. Company overview
    • 7.3.2. Company snapshot
    • 7.3.3. Operating business segments
    • 7.3.4. Product portfolio
    • 7.3.5. Business performance
  • 7.4. BIOMERIEUX SA
    • 7.4.1. Company overview
    • 7.4.2. Company snapshot
    • 7.4.3. Operating business segments
    • 7.4.4. Product portfolio
    • 7.4.5. Business performance
  • 7.5. Bio-Rad Laboratories, Inc.
    • 7.5.1. Company overview
    • 7.5.2. Company snapshot
    • 7.5.3. Operating business segments
    • 7.5.4. Product portfolio
    • 7.5.5. Business performance
  • 7.6. Meridian Bioscience Inc.
    • 7.6.1. Company overview
    • 7.6.2. Company snapshot
    • 7.6.3. Operating business segments
    • 7.6.4. Product portfolio
    • 7.6.5. Business performance
    • 7.6.6. Key strategic moves and developments
  • 7.7. NOVARTIS AG
    • 7.7.1. Company overview
    • 7.7.2. Company snapshot
    • 7.7.3. Operating business segments
    • 7.7.4. Product portfolio
    • 7.7.5. Business performance
  • 7.8. Olympus Corporation
    • 7.8.1. Company overview
    • 7.8.2. Company snapshot
    • 7.8.3. Operating business segments
    • 7.8.4. Product portfolio
    • 7.8.5. Business performance
  • 7.9. Premier Medical Corporation Pvt Ltd.
    • 7.9.1. Company overview
    • 7.9.2. Company snapshot
    • 7.9.3. Operating business segments
    • 7.9.4. Product portfolio
  • 7.10. SIEMENS
    • 7.10.1. Company overview
    • 7.10.2. Company snapshot
    • 7.10.3. Operating business segments
    • 7.10.4. Product portfolio
    • 7.10.5. Business performance
    • 7.10.6. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL MALARIA DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2018-2026 ($THOUSAND)
  • TABLE 02. RAPID DIAGNOSTIC TESTS MALARIA DIAGNOSTICS MARKET, BY REGION, 2018-2026 ($THOUSAND)
  • TABLE 03. MICROSCOPY MALARIA DIAGNOSTICS MARKET, BY REGION, 2018-2026 ($THOUSAND)
  • TABLE 04. MOLECULAR DIAGNOSTIC TESTS MALARIA DIAGNOSTICS MARKET, BY REGION, 2018-2026 ($THOUSAND)
  • TABLE 05. GLOBAL MALARIA DIAGNOSTICS MARKET, BY END USER, 2018-2026 ($THOUSAND)
  • TABLE 06. MALARIA DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2018-2026 ($THOUSAND)
  • TABLE 07. MALARIA DIAGNOSTICS MARKET FOR CLINICS, BY REGION, 2018-2026 ($THOUSAND)
  • TABLE 08. MALARIA DIAGNOSTICS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2018-2026 ($THOUSAND)
  • TABLE 09. MALARIA DIAGNOSTICS MARKET, BY REGION, 2018-2026 ($THOUSAND)
  • TABLE 10. NORTH AMERICA MALARIA DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2019-2026 ($THOUSAND)
  • TABLE 11. U.S. MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 12. U.S. MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 13. CANADA MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 14. CANADA MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 15. NORTH AMERICA MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026($THOUSAND)
  • TABLE 16. NORTH AMERICA MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026($THOUSAND)
  • TABLE 17. EUROPE MALARIA DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2019-2026 ($THOUSAND)
  • TABLE 18. GERMANY MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 19. GERMANY MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 20. UK MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 21. UK MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 22. REST OF EUROPE MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 23. REST OF EUROPE MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 24. EUROPE MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026($THOUSAND)
  • TABLE 25. EUROPE MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026($THOUSAND)
  • TABLE 26. ASIA-PACIFIC MALARIA DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2019-2026 ($THOUSAND)
  • TABLE 27. INDIA MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 28. INDIA MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 29. CHINA MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 30. CHINA MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 31. REST OF ASIA-PACIFIC MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 32. REST OF ASIA-PACIFIC MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 33. ASIA-PACIFIC MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026($THOUSAND)
  • TABLE 34. ASIA-PACIFIC MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026($THOUSAND)
  • TABLE 35. LAMEA MALARIA DIAGNOSTICS MARKET REVENUE, BY COUNTRY, 2019-2026 ($THOUSAND)
  • TABLE 36. ARICA MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 37. ARICA MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 38. REST OF LAMEA MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026 ($THOUSAND)
  • TABLE 39. REST OF LAMEA MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026 ($THOUSAND)
  • TABLE 40. LAMEA MALARIA DIAGNOSTICS MARKET REVENUE, BY PRODUCT TYPE, 2019-2026($THOUSAND)
  • TABLE 41. LAMEA MALARIA DIAGNOSTICS MARKET REVENUE, BY END USER, 2019-2026($THOUSAND)
  • TABLE 42. ABBOTT: COMPANY SNAPSHOT
  • TABLE 43. ABBOTT: OPERATING SEGMENTS
  • TABLE 44. ABBOTT: PRODUCT PORTFOLIO
  • TABLE 45. ACCESSBIO: COMPANY SNAPSHOT
  • TABLE 46. ACCESSBIO: OPERATING SEGMENTS
  • TABLE 47. ACCESSBIO: PRODUCT PORTFOLIO
  • TABLE 48. ATLAS MEDICAL: COMPANY SNAPSHOT
  • TABLE 49. ATLAS MEDICAL: PRODUCT PORTFOLIO
  • TABLE 50. BIOMERIEUX.: COMPANY SNAPSHOT
  • TABLE 51. BIOMERIEUX.: OPERATING SEGMENTS
  • TABLE 52. BIOMERIEUX: PRODUCT PORTFOLIO
  • TABLE 53. BIO-RAD: COMPANY SNAPSHOT
  • TABLE 54. BIO-RAD: OPERATING SEGMENTS
  • TABLE 55. BIO-RAD: PRODUCT PORTFOLIO:
  • TABLE 56. MERIDIAN: COMPANY SNAPSHOT
  • TABLE 57. MERIDIAN: OPERATING SEGMENTS
  • TABLE 58. MERIDIAN: PRODUCT PORTFOLIO
  • TABLE 59. NOVARTIS: COMPANY SNAPSHOT
  • TABLE 60. NOVARTIS: OPERATING SEGMENTS
  • TABLE 61. NOVARTIS: PRODUCT PORTFOLIO
  • TABLE 62. OLYMPUS: COMPANY SNAPSHOT
  • TABLE 63. OLYMPUS: OPERATING SEGMENTS
  • TABLE 64. OLYMPUS: PRODUCT PORTFOLIO
  • TABLE 65. PREMIER MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 66. PREMIER MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 67. PREMIER MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 68. SIEMENS: COMPANY SNAPSHOT
  • TABLE 69. SIEMENS: OPERATING SEGMENTS
  • TABLE 70. SIEMENS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. GLOBAL MALARIA DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 02. TOP PLAYER POSITIONING, 2018
  • FIGURE 03. TOP INVESTMENT POCKETS
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIER
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. HIGH INTENSITY OF RIVALRY
  • FIGURE 08. LOW THREAT OF NEW ENTRANT
  • FIGURE 09. IMPACT ANALYSES, MALARIA DIAGNOSTICS MARKET
  • FIGURE 10. COMPARATIVE SHARE ANALYSIS OF RAPID DIAGNOSTIC TESTS MALARIA DIAGNOSTICS MARKET, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MICROSCOPY MALARIA DIAGNOSTICS MARKET, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MOLECULAR DIAGNOSTIC TESTS MALARIA DIAGNOSTICS MARKET, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MALARIA DIAGNOSTICS MARKET FOR HSOPITALS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MALARIA DIAGNOSTICS MARKET FOR CLINICS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MALARIA DIAGNOSTICS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2018 & 2026 (%)
  • FIGURE 16. U.S. MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 17. CANADA MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 18. GERMANY MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 19. UK MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 20. REST OF EUROPE MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 21. INDIA MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 22. CHINA MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 23. REST OF ASIA-PACIFIC MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 24. ARICA MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 25. REST OF LAMEA MALARIA DIAGNOSTICS MARKET, 2018-2026 ($THOUSAND)
  • FIGURE 26. ABBOTT: NET SALES, 2016-2018 ($THOUSAND)
  • FIGURE 27. ABBOTT: REVENUE SHARE BY SEGMENT, 2018(%)
  • FIGURE 28. ABBOTT: REVENUE SHARE BY REGION, 2018(%)
  • FIGURE 29. BIOMERIEUX: NET SALES, 2018-2019 ($THOUSAND)
  • FIGURE 30. BIO-RAD: NET SALES, 2016-2018 ($THOUSAND)
  • FIGURE 31. BIO-RAD: REVENUE SHARE BY SEGMENTS, 2018(%)
  • FIGURE 32. BIO-RAD: REVENUE SHARE BY REGION, 2018 (%)
  • FIGURE 33. MERIDIAN: NET SALES, 2016-2018 ($THOUSAND)
  • FIGURE 34. MERIDIAN: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 35. MERIDIAN: REVENUE SHARE BY REGION, 2018(%)
  • FIGURE 36. NOVARTIS: NET SALES, 2016-2018 ($THOUSAND)
  • FIGURE 37. NOVARTIS: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 38. NOVARTIS: REVENUE SHARE BY REGION, 2018 (%)
  • FIGURE 39. OLYMPUS CORPORATION: NET SALES, 2016-2018 ($THOUSAND)
  • FIGURE 40. OLYMPUS: REVENUE SHARE BY SEGMENTS, 2018(%)
  • FIGURE 41. OLYMPUS: REVENUE SHARE BY REGION, 2018 (%)
  • FIGURE 42. NET SALES, 2016-2018 ($THOUSAND)
  • FIGURE 43. SIEMENS: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 44. SIEMENS: REVENUE SHARE BY REGION, 2018 (%)